Danaher Group (NYSE: DHR), with its four strategic platforms and 15 sub-brands, was unveiled at the 3rd China International Import Expo (hereinafter referred to as "China Import Expo") with the theme of "One Heart and Healthy". This is the third consecutive year that Danaher has participated in this global event. As the company with the largest booth area in the public health and epidemic prevention zone of the 3rd CIIE, Danaher's booth is to fight against the new crown, smart laboratories, life sciences and Situ Four special areas such as Cytiva fully demonstrated its world-leading products and overall solutions in the fields of medical diagnosis, life sciences, etc. to the visiting governments, enterprises, media and professional audiences. Ten signing events.
With the normalization of epidemic prevention and control and the advent of the flu season, clinicians will encounter a series of viral infections with clinical symptoms similar to those of new coronary pneumonia. At the CIIE, Danaher and its operating company, Cyper, displayed a set of rapid molecular testing kits that have just been authorized by the US Food and Drug Administration for emergency use. This product can use a single kit to detect four viruses with similar symptoms in patient samples at the same time with high sensitivity, realizing the qualitative detection of new coronavirus (SARS-CoV-2), influenza A, influenza B and respiratory syncytial virus (RSV) , Results can be obtained in only 36 minutes, providing a practical basis for clinical diagnosis, while greatly reducing the pressure on the medical system and avoiding the risk of epidemic transmission.
During the CIIE, Danaher will also invite Professor Zhang Wenhong, Director of the Department of Infectious Diseases, Huashan Hospital Affiliated to Fudan University, Professor Lu Hongzhou, Party Secretary of Shanghai Public Health Clinical Center, and Professor Hao Xiaoke, Director of the Clinical Laboratory Medicine Laboratory of Xijing Hospital , Professor Wu Wenjuan, Director of the Department of Laboratory Medicine, Southern Branch of Oriental Hospital Affiliated to Shanghai Tongji University, and Professor Tang Yiwei, Chief Medical Officer of Danaher Diagnostic Platform China, had a roundtable discussion on how to deal with public health challenges and thinking about the industry in medical testing.
The CIIE is not only a gathering place for the world's leading technologies, but also an exchange platform to promote multi-party cooperation between government, enterprise, industry, academia and research, and a trading platform that turns "exhibits" into "commodities". During the Expo, Danaher is expected to reach nearly 20 cooperation intentions and sign strategic agreements with multiple partners such as governments at all levels, the pharmaceutical industry, third-party independent laboratories, platform distributors, and medical institutions.